Home
>
National Drug Code (NDC)
>
Actoplus Met
Actoplus Met - 64764-155-18 - (pioglitazone and metformin hydrochloride)
Drug Information of Actoplus Met
| Product NDC: | 64764-155 |
| Proprietary Name: | Actoplus Met |
| Non Proprietary Name: | pioglitazone and metformin hydrochloride |
| Active Ingredient(s): | 500; 15 mg/1; mg/1 & nbsp; pioglitazone and metformin hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Actoplus Met
| Product NDC: | 64764-155 |
| Labeler Name: | Takeda Pharmaceuticals America, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021842 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050829 |
Package Information of Actoplus Met
| Package NDC: | 64764-155-18 |
| Package Description: | 180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64764-155-18) |
NDC Information of Actoplus Met
| NDC Code | 64764-155-18 |
| Proprietary Name | Actoplus Met |
| Package Description | 180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64764-155-18) |
| Product NDC | 64764-155 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pioglitazone and metformin hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20050829 |
| Marketing Category Name | NDA |
| Labeler Name | Takeda Pharmaceuticals America, Inc. |
| Substance Name | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
| Strength Number | 500; 15 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
